Opana ER
FDA Asks Endo Pharma to Pull Opana ER
Jun 09, 2017 at 11:42 am by Staff
In a highly unusual move, the U.S. Food and Drug Administration has requested Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydroc.... Read More